Pepe, M. S., Janes, H., Li, C. I., Bossuyt, P. M., Feng, Z., & Hilden, J. (2016). Early-Phase Studies of Biomarkers: What Target Sensitivity and Specificity Values Might Confer Clinical Utility? Clinical chemistry (Baltimore, Md.), 62(5), 737-742. https://doi.org/10.1373/clinchem.2015.252163
Citácia podle Chicago (17th ed.)Pepe, Margaret S., Holly Janes, Christopher I. Li, Patrick M. Bossuyt, Ziding Feng, a Jørgen Hilden. "Early-Phase Studies of Biomarkers: What Target Sensitivity and Specificity Values Might Confer Clinical Utility?" Clinical Chemistry (Baltimore, Md.) 62, no. 5 (2016): 737-742. https://doi.org/10.1373/clinchem.2015.252163.
Citácia podľa MLA (8th ed.)Pepe, Margaret S., et al. "Early-Phase Studies of Biomarkers: What Target Sensitivity and Specificity Values Might Confer Clinical Utility?" Clinical Chemistry (Baltimore, Md.), vol. 62, no. 5, 2016, pp. 737-742, https://doi.org/10.1373/clinchem.2015.252163.